SCHEMBL24210550

SCHEMBL24210550

CC(C)C(C)Cc1ccccc1F

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.45
IDO1 P14902 2/20 0.42
AOC3 Q16853 1/20 0.41
SLC6A2 P23975 4/20 0.41
SLC6A3 Q01959 4/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2D6 P10635 3/20 0.41
SLC6A4 P31645 3/20 0.41
KCNH2 Q12809 2/20 0.41
LMNA P02545 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15160739 0.83 TAAR1 (0.45) TAAR1IDO1AOC3SLC6A2SLC6A3
SCHEMBL139640 0.82 GABRA1 (0.52) TAAR1IDO1AOC3SLC6A2SLC6A3
Hydrochloric Acid SCHEMBL4680288 0.82 CYP2D6 (0.52) TAAR1IDO1AOC3SLC6A2SLC6A3
SCHEMBL24967350 0.79 TAAR1 (0.42) TAAR1IDO1AOC3SLC6A2SLC6A3
SCHEMBL5680506 0.79 TAAR1 (0.42) TAAR1IDO1AOC3SLC6A2SLC6A3
SCHEMBL2563200 0.78 TAAR1 (0.50) TAAR1IDO1AOC3SLC6A2SLC6A3
SCHEMBL22204358 0.78 TAAR1 (0.45) TAAR1IDO1AOC3SLC6A2SLC6A3
SCHEMBL3238216 0.78 TAAR1 (0.50) TAAR1IDO1AOC3SLC6A2SLC6A3
SCHEMBL14478267 0.78 TAAR1 (0.50) TAAR1IDO1AOC3SLC6A2SLC6A3
SCHEMBL15082795 0.78 TAAR1 (0.45) TAAR1IDO1AOC3SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017541-A1 INHIBITORS OF ARGINASE Praxis Biotech LLC 2022-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017541-A1 INHIBITORS OF ARGINASE ARG1, ARG2, ARGLU1 TAAR1 1533/4885IDO1 167/4885AOC3 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.